HomeCAPS • NASDAQ
add
Capstone Therapeutics Corp
Previous close
$2.41
Day range
$2.37 - $2.60
Year range
$1.65 - $4.18
Market cap
12.86M USD
Avg Volume
693.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 10.31M | 8.73% |
Operating expense | 2.42M | 10.11% |
Net income | -1.10M | 45.37% |
Net profit margin | -10.70 | 49.74% |
Earnings per share | — | — |
EBITDA | -101.00K | 86.30% |
Effective tax rate | -61.49% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.00K | -78.85% |
Total assets | 47.22M | -10.40% |
Total liabilities | 20.66M | -12.37% |
Total equity | 26.56M | — |
Shares outstanding | 5.19M | — |
Price to book | -0.12 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.10M | 45.37% |
Cash from operations | 2.84M | 77.70% |
Cash from investing | -19.00K | 54.76% |
Cash from financing | -2.83M | -77.97% |
Net change in cash | -2.00K | 93.33% |
Free cash flow | — | — |
About
Founded
1987
Headquarters
Website
Employees
36
